Contributors

Joshua Fredell, PharmD

Vice President & Head of PBM & Specialty Product Innovation
Joshua Fredell, Vice President & Head of PBM & Specialty Product Innovation

During his 16 years with the organization, Fredell has focused on the ideation, commercialization and ongoing management of clinical products and services ranging from those designed to manage unnecessary pharmacy spend improving overall healthcare through adherence and closing gaps in care. Currently, he and his team are focused on evolving formulary and cost management strategies within both the pharmacy and medical benefits including designs for utilization management, preferred drug strategies, value-based contracting, and plan design programs. Prior to CVS Health, Fredell was part of the pharmacy department of UPMC Health Plan and earned his PharmD from the University of Pittsburgh.

Drug Pipeline
Keeping an Eye on the Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon More
Briefing
Cost Management
2023 CVS Caremark Formulary Updates
CVS Caremark Announces Formulary Changes for 2023 More
Briefing
Specialty
Multiple Specialty Vendors Mean More Headaches
Multiple Specialty Vendors Mean More Headaches More
Commentary
Drug Pipeline
Anticipating a Breakthrough Therapy for Type 1 Diabetes
Teplizumab: Potential Breakthrough Therapy for Type 1 Diabetes More
Briefing
Cost Management
Reducing Wasteful Spend on High-Cost, Low-Value Drugs
CVS Health’s Hyperinflation Strategy Helps Clients Reduce Unnecessary Drug Spend More
Briefing
Cost Management
The Power of Integration
White Paper: The Power of Integrated Specialty Cost Management More
White Paper
Don’t fall for the carve-out hype
... More
Programs & Services Video
Cost Management
Strategy and Balance: Managing Costs for Pulmonary Arterial Hypertension
Managing Treatment Costs for Pulmonary Arterial Hypertension More
Briefing